BlueCrest Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-150,000
| Closed | -$1.48M | – | 282 |
|
|
2021
Q4 | $1.48M | Hold |
150,000
| – | – | 0.05% | 178 |
|
|
2021
Q3 | $1.49M | Hold |
150,000
| – | – | 0.04% | 205 |
|
|
2021
Q2 | $1.55M | Hold |
150,000
| – | – | 0.03% | 308 |
|
|
2021
Q1 | $1.53M | Hold |
150,000
| – | – | 0.03% | 462 |
|
|
2020
Q4 | $1.71M | Buy |
+150,000
| New | +$1.71M | 0.04% | 245 |
|